The mitogen-activated protein kinase (MAPK) signaling pathway regulates various cellular functions, including those induced by Helicobacter pylori. TAK1 is an upstream MAPK kinase kinase (MAP3K) required for H. pylori-induced MAPK and NF-B activation, but it remains unclear whether other MAP3Ks are involved in H. pylori-induced cellular responses. In this study, we focused on the MAP3K ASK1, which plays a critical role in gastric tumorigenesis. In gastric epithelial cells, H. pylori activates ASK1 in a reactive oxygen species (ROS)-and cag pathogenicity island-dependent manner, and ASK1 regulates sustained JNK activation and apoptosis induced by H. pylori. In contrast, TAK1 regulates H. pylori-mediated early JNK activation and cytokine production. We also found reciprocal regulation between ASK1 and TAK1 in H. pylori-related responses, whereby inhibition of TAK1 or downstream p38 MAPK activates ASK1 through ROS production, and ASK1 suppresses TAK1 and downstream NF-B activation. We identified ROS/ASK1/JNK as a new signaling pathway induced by H. pylori, which regulates apoptotic cell death. The balance of ASK1-induced apoptosis and TAK1-induced antiapoptotic or inflammatory responses may determine the fate of epithelial cells infected with H. pylori and thus be involved in the pathogenesis of gastritis and gastric cancer.
T he mitogen-activated protein kinase (MAPK) signaling pathway is involved in various cellular functions, including cell cycle, apoptosis, inflammatory responses, and differentiation (1) . This pathway consists of three sequential kinases, MAPK kinase kinase (MAP3K), MAPK kinase (MAP2K), and MAPK. More than 20 kinds of MAP3Ks regulate different and distinct functions depending on the stimuli or stresses involved (2) .
Apoptosis signal-regulating kinase 1 (ASK1) is a MAP3K that regulates apoptosis, immune responses, and carcinogenesis (3) (4) (5) . ASK1 binds directly to thioredoxin (TRX), a reduction/oxidation regulatory protein, and intracellular reactive oxygen species (ROS) can activate ASK1 by dissociating it from TRX (6) . ASK1 activates the downstream MAPKs c-Jun-N-terminal kinase (JNK) and p38 through phosphorylation of the MAP2Ks, MKK4, and MKK3. ASK1 and subsequent MAPK activation are involved in various human diseases (7, 8) , and we reported previously that ASK1 plays critical roles in the development of colitis, colon cancer, liver injury, liver cancer, and gastric cancer (9) (10) (11) (12) (13) .
Gastric cancer is one of the most common cancers worldwide, and Helicobacter pylori is known to be a critical risk factor for the disease (14) . It has been reported that H. pylori and its virulence factor cag pathogenicity island (PAI) activates nuclear factor-B (NF-B) and MAPK signaling through MyD88 and TAK1 activation (15) (16) (17) (18) (19) (20) . The activation of these signaling pathways is important for the cytokine production or cell proliferation that leads to the development of gastric cancer (21) (22) (23) (24) . However, the relationship between H. pylori and ASK1 in epithelial cells has not been fully investigated.
TAK1 positively and negatively regulates JNK activity in an ROSdependent manner (25) (26) (27) (28) , and TAK1 negatively regulates ASK1 activation via TAB1 binding activity (29) . In contrast, ASK1 inhibits the effect of TAK1 on interleukin-1␤ (IL-1␤)-dependent NF-B activation (30) . However, it is not clear how ASK1 and TAK1 are involved in H. pylori-induced cellular responses. Here we show that ASK1 is activated by H. pylori and regulates ROS-mediated and JNKdependent apoptosis. We further demonstrate that ASK1 and TAK1 have reciprocal functions in gastric epithelial cells.
MATERIALS AND METHODS
Cell lines. Human gastric cell lines, AGS and MKN45, were cultured in Ham F-12 or RPMI medium, supplemented with 10% fetal bovine serum. For signaling pathway analysis, cells were pretreated for 30 min with the JNK inhibitor SP600125 (Biomol, Plymouth Meeting, PA), the p38 inhibitor SB203580 (Wako, Osaka, Japan), the IKK␤ inhibitor SC-514 (Wako) dissolved in dimethyl sulfoxide (DMSO), or the ROS inhibitor N-acetylcysteine (NAC; Wako) dissolved in serum-free cell culture medium. In the control group, appropriate vehicle was added in the culture media.
H. pylori strains. The Helicobacter strains used in the present study were H. pylori TN2 and TN2-⌬PAI, which lacks the cag PAI gene cluster (15) . H. pylori was cultured as described previously (23) . Prior to use, these bacterial strains were washed with phosphate-buffered saline (PBS), and concentrations estimated using an optical density at 560 nm of 0.1 as an equivalent to 4 ϫ 10 7 CFU of H. pylori. The bacteria were resuspended in Ham F-12 or RPMI before infection. Infections were performed by washing cultured cells twice with PBS, adding fresh serum-free medium without antibiotics in order to avoid MAPK activation by serum, and adding H. pylori for the indicated time periods at a multiplicity of infection of 100.
siRNA transfection. RNA oligonucleotides were synthesized by Qiagen (Hilden, Germany). All siRNA transfections were performed with RNAiMAX according to the manufacturer's instructions (Invitrogen Life Technologies, Carlsbad, CA). Small interfering RNAs (siRNAs) were used as a concentration of 80 nM and verified by demonstrating a 75% reduction of the target protein in cells by real-time PCR or immunoblotting.
Adenovirus vectors. LacZ-and ASK1-expressing adenoviruses have been described previously (31) . Cells were seeded into 12-well plates, infected with adenoviruses for 24 h, and used for assays.
RNA analysis. Total RNA was extracted with the use of the Nucleospin RNA II kit (TaKaRa, Japan). First-strand cDNA was synthesized with the use of an ImProm-II reverse transcription system (Promega, Madison, WI). Amplification was performed with an ABI Prism 7000 quantitative PCR system (Applied Biosystems, Foster City, CA). The various mRNAs were quantitated by real-time PCR, and their expression was normalized to that of GAPDH (glyceraldehyde-3-phosphate dehydrogenase). The primer sequences used are available upon request. Samples were prepared in triplicate, and two independent experiments were performed.
Western blotting and immunoprecipitation. Western blotting and immunoprecipitation were performed as described previously (32) . Antiphospho-ERK, anti-p38, anti-phospho-JNK, anti-JNK, anti-phosphop38, anti-phospho-MKK4, anti-phospho-ASK1, anti-phospho-TAK1, anti-Bim, anti-phospho-IB-␣, and anti-cleaved caspase-3 antibodies were purchased from Cell Signaling Technology (Danvers, MA). Anti-TAK1 antibodies were purchased from Stressgen (Ann Arbor, MI). Anti-TRAF6 and anti-IB-␣ antibodies were acquired from Santa Cruz. Anti-␤-actin antibodies were purchased from Sigma-Aldrich and anti-ASK1 antibodies were obtained as described previously (31, 33) .
A minimum of two independent experiments were performed. Quantification of the protein level was determined by densitometry using ImageJ software.
Analysis of ROS production and apoptosis by flow cytometry. ROS production was detected by using the cell-permeable fluorogenic probe dichlorofluorescein diacetate (DCF-DA; Molecular Probes, USA). Cells were incubated with 10 M DCF-DA for 10 min, harvested by trypsinization, and washed with PBS. Intracellular ROS were analyzed by flow cytometry with the Guava EasyCyte Plus (Guava Technologies, Haryana, India). Propidium iodide (PI) was added immediately before acquiring the samples, and the live cells were gated (PI negative). For apoptosis analysis, cells were stimulated with H. pylori for 24 h and harvested by trypsinization. Apoptotic cells were analyzed by flow cytometry using the Guava Nexin reagent (Millipore). For every sample, 10,000 events were acquired. Samples were prepared in triplicate, and two independent experiments were performed.
Plasmid transfection and luciferase assays. Cells were seeded into 12-well plates and after 24 h were transfected with 200 ng of NF-B Luc and 200 ng of the indicated expression vectors using Effectene transfection reagent (Qiagen). To standardize transfection efficiency, 10 ng of the Renilla luciferase vector (Promega, Madison, WI) was included in each sample. The total DNA concentration was kept constant through the addition of empty pcDNA3.1 vector (Invitrogen, Carlsbad, CA). After 24 h, the cells were harvested in luciferase lysis buffer (Piccagene; Toyo Ink, Tokyo, Japan). The lysates were assayed for luciferase and Renilla luciferase activities using a luminometer. The ratio of reporter luciferase activity to the Renilla luciferase control was used to standardize luciferase activity to transfection efficiency. The data are presented as fold inductions compared to the control. Samples were prepared in triplicate, and two independent experiments were performed.
Statistical analysis. The differences between means were compared by using a Student t test or the Wilcoxon test. P values of Ͻ0.05 were considered statistically significant.
RESULTS

ASK1
is activated by H. pylori in a ROS-and cag PAI-dependent manner. We initially investigated whether ASK1 was activated by H. pylori in gastric epithelial cells. Immunoprecipitation analysis revealed that endogenous ASK1 was gradually phosphorylated after H. pylori stimulation of AGS cells (Fig. 1A, left) . Quantification of phospho-ASK1 expression level per total ASK1 expression level indicated that the phosphorylation was maximum at 3 h after H. pylori stimulation (Fig. 1A, (Fig. 2, A and B) . In cells transfected with ASK1-targeting siRNA (ASK1 siRNA), the phosphorylation of most of these MAPKs seemed to be similar to cells transfected with control siRNA (NC siRNA), while cyclin D1 expression was greatly suppressed ( Fig. 2A ) as reported previously (11) . However, JNK phosphorylation after 2 h of stimulation was significantly decreased compared to NC siRNA transfected cells ( Fig. 2A and B, arrows). In contrast, adenovirus-mediated ASK1 overexpression increased late-phase JNK phosphorylation, as well as ASK1 phosphorylation (Fig. 2C, arrows) . NAC treatment inhibited sustained JNK phosphorylation after H. pylori stimulation but not p38, ERK, and NF-B activation (Fig. 2D, arrows) , suggesting that the activation of ASK1 by H. pylori specifically regulates sustained JNK activation through a ROS-dependent pathway.
TAK1 regulates H. pylori-induced early JNK and p38 activation and inhibits ASK1 activation through controlling intracellular ROS. TAK1 is another major MAP3K that regulates JNK activation, and we have reported that TAK1 is required for H. pyloriinduced JNK activation (16) . In the present study, we investigated the time course of TAK1-stimulated JNK activation. As reported previously (16), TAK1 knockdown significantly reduced the levels of JNK and p38 phosphorylation, but not the phosphorylation of ERK, and this reduction started 0.5 h after H. pylori coculture (Fig. 3A, arrows) . Although even late-phase p38 phosphorylation was decreased, latephase JNK phosphorylation in TAK1 knockdown cells was gradually increased (Fig. 3A) . These results were confirmed by densitometry and suggest that TAK1 induces early-phase but does not affect latephase JNK phosphorylation.
TAK1 has recently been reported to negatively regulate ROS production and subsequent JNK activation (25) (26) (27) 35) . Thus, we investigated the effect of TAK1 inhibition on H. pylori-related ROS production and ASK1 activation. Immunoprecipitation analysis showed that endogenous ASK1 phosphorylation in TAK1-knockdown cells was greater than control cells after H. pylori stimulation (Fig. 3B) . Similar findings were obtained in ASK1-overexpressing cells (Fig. 3C ). When we compared ROS production by H. pylori in cells transfected with negative control or TAK1 siRNA, we found greater ROS production in TAK1-knockdown cells than in control cells ( Fig. 3D and E) . These results suggest that TAK1 inhibition enhances H. pylori-induced ROS production, subsequent ASK1 activation, and late-phase JNK activation.
Reciprocal inhibition between ASK1 and TAK1 in H. pyloriinduced signal transduction. When we knocked down both TAK1 and ASK1 in epithelial cells, it abolished both early and late JNK phosphorylation after H. pylori stimulation (Fig. 4A ). Previous study reported that ASK1 could activate downstream molecules by binding to TRAF6 (4). Knockdown of TRAF6 inhibited both early-and late-phase JNK activation induced by H. pylori (Fig. 4B) . Therefore, TRAF6 might be necessary for the activation of both ASK1-and TAK1-dependent pathways. We further investigated whether ASK1 has an inhibitory effect on TAK1 activity. Indeed, ASK1 knockdown by siRNA increases the phosphorylation of TAK1 and downstream IB-␣ after H. pylori stimulation (Fig. 4C) . Luciferase assays revealed that the overexpression of ASK1 inhibited NF-B activation after H. pylori stimulation, whereas TAK1 overexpression enhanced NF-B activation (Fig.  4D ). These results demonstrate reciprocal effects between ASK1 and TAK1 on H. pylori-induced signal transduction. ASK1 and TAK1 differentially regulate H. pylori-induced apoptosis and cytokine production. We assessed the effect of ASK1 and sustained JNK activation in cells infected with H. pylori. Since ASK1 is reported to be a critical regulator of apoptosis caused by various stimuli (3-5), we evaluated H. pylori-induced apoptotic responses. After H. pylori coculture, flow cytometric analysis revealed that the numbers of apoptotic cells were increased (Fig. 5A) , suggesting that H. pylori TN2 could induce apoptosis in gastric epithelial cells, as reported previously (36) . We found that the numbers of apoptotic cells were decreased in cells transfected with ASK1 siRNA or treated with NAC (Fig. 5A) . NAC treatment alone did not affect the number of apoptotic cells without H. pylori stimulation (data not shown). In addition, stimulation with TN2⌬PAI failed to significantly induce apoptosis (Fig. 5A) . These results suggest that the cag PAI-ROS-ASK1 pathway is important for H. pylori-induced apoptosis. Immunoblot analysis also revealed that cleavage of caspase-3 was decreased in cells transfected with ASK1 siRNA after H. pylori stimulation compared to control cells (Fig. 5B) . Knockdown of ASK1 also reduced the levels of phosphorylated JNK and BimEL (Fig. 5B) , while overexpression of ASK1 increased the levels of cleaved caspase-3 and BimEL (Fig. 5C ). Treatment with JNK inhibitor SP600125 significantly reduced early-and late-phase JNK activation after H. pylori stimulation (Fig. 5D) . We observed that SP600125 or NAC significantly suppressed apoptotic responses after H. pylori coculture (Fig. 5E ). These results suggest that JNK and BimEL could be downstream effectors of ASK1-mediated apoptosis. In contrast, cells transfected with TAK1 siRNA showed higher levels of cleaved caspase-3 after H. pylori treatment than control cells (Fig. 5B) . Increased apoptosis induced by TAK1 knockdown was diminished by NAC, ASK1 knockdown, and SP600125 (Fig. 5F ). These results suggest that H. pylori-induced apoptosis is positively regulated by ASK1 and negatively regulated by TAK1 through ROS and sustained JNK activation.
Even though TAK1 inhibition enhanced apoptosis, there was no upregulation of BimEL level in TAK1 knockdown cells. Thus, we evaluated the expression of antiapoptotic genes known to be regulated by NF-B or p38 activation, including A20, cIAP1, cIAP2, and Serpin B2. H. pylori infection enhanced the expression of these antiapoptotic genes in control cells, while siRNA for TAK1 significantly decreased their expression (Fig. 6A) . Interestingly, ASK1 knockdown cells expressed higher levels of cIAP1, cIAP2, and Serpin B2 genes than control cells (Fig. 6A) . These results suggest that the differential regulation of antiapoptotic genes by each MAP3K is also important for H. pylori-induced apoptosis.
H. pylori induces the production of various cytokines in gastric epithelial cells through the MAPK pathway (15, 17, 19) . In the present study we investigated whether ASK1 affected cytokine production induced by H. pylori. Although uninfected cells with ASK1 or TAK1 siRNA showed similar low levels of all cytokines to control cells (data not shown), knockdown of TAK1 or treatment with the JNK inhibitor SP600125 decreased the production of IL-8, IL-1, and tumor necrosis factor alpha (TNF-␣) after H. pylori stimulation as reported previously (16, 37) , suggesting involvement of TAK1 and early JNK activation in H. pylori-induced cytokine production. When cells were transfected with ASK1 siRNA or treated with NAC, the levels of IL-1␤ and TNF-␣ were significantly reduced, as seen in TAK1 siRNA-or SP600125-treated cells, whereas the production of IL-8 and IL-1␣ was not suppressed (Fig. 6B) . Treatment with SP600125 or NAC alone without H. pylori did not change gene expression levels (data not shown). These results indicate that cytokines induced by H. pylori mediated either ROS-dependent (ASK1-dependent) or -independent (ASK1-independent but TAK1-dependent) pathways. Therefore, TAK1 and ASK1 differentially regulate H. pylori-induced cytokine production and apoptosis through ROS production and JNK activation.
H. pylori-induced ASK1 activation is enhanced by p38 MAPK inhibition through ROS production. Although previous reports showed that inhibition of p38 MAPK activity caused compensatory JNK and ERK activation through ROS production (38-43), it has not been reported whether these MAPK interactions are induced by H. pylori infection. Thus, we assessed the relationship between downstream MAPK and ROS in the setting of H. pylori infection. Treatment with 10 M SB203580, a p38 MAPK inhibitor, significantly increased intracellular ROS following H. pylori stimulation (Fig. 7A) . Treatment with 10 M SC-514, an IKK-␤ inhibitor, did not enhance ROS production by H. pylori (Fig. 7A) . The effects of these inhibitors at these concentrations were confirmed by immunoblotting (see Fig. S1 in the supplemental material). When we investigated the activation of ASK1 and downstream kinases in cells treated with or without SB203580, treatment with SB203580 increased the phosphorylation of ASK1 and JNK compared to treatment with the DMSO vehicle [ Fig. 7B , Hp(Ϫ)-untreated lanes]. Treatment with SB203580 enhanced the phosphorylation of MKK4, but did not enhance ERK and p38 phosphorylation (Fig. 7C, NC siRNA-treated lanes) . Inhibitor of p38 also increased H. pyroli-induced ASK1 and JNK phosphorylation [ Fig. 7B , Hp(ϩ)-treated lanes]. Enhancement of JNK and MKK4 phosphorylation (with or without H. pylori) was reduced by ASK1 knockdown (Fig. 7C and D) , suggesting that these compensatory interactions among MAPK pathways are ASK1 dependent. Furthermore, we observed that SB203580 increased H. pylori-induced apoptosis and that this increase was inhibited by SP600125 treatment or ASK1 knockdown (Fig. 7E) , suggesting that activation of the ASK1-JNK pathway after p38 inhibition was important for H. pylori-induced apoptosis. In contrast, p38 activation may counteract these apoptotic effects through ROS inhibition and antiapoptotic gene induction.
In summary, ASK1 is involved in the cellular responses, such as apoptosis and cytokine production, induced by H. pylori. Furthermore, ASK1 and TAK1 have reciprocal interactions, and differentially regulate the activation of downstream molecules, such as JNK, p38, or NF-B. A downstream molecule p38 could, in turn, affect ASK1 activation through ROS production (Fig. 7F) . We conclude that ASK1 is a key player in the regulation of H. pylorirelated cellular responses in gastric epithelial cells.
DISCUSSION
In this study, we used gastric epithelial cells to investigate the role of ASK1 in H. pylori-induced cellular responses and MAPK pathway interactions. We identified ROS-ASK1-sustained JNK activation as a new signaling pathway activated by H. pylori and showed that this pathway is important in H. pylori-induced apoptosis. Furthermore, we found that ASK1 plays critical roles in various ROS-dependent interactions via MAPK signaling. It has been reported that H. pylori induces AP-1 activation through ERK, JNK, or p38 activation by type IV secretion system in gastric epithelial cells (15) (16) (17) (18) (19) (20) (44) (45) (46) (47) (48) . Various upstream molecules in this pathway have been identified, such as NF-B-inducing kinase (NIK), Raf, TAK1, Nod1, and p21-activated kinase 1 (PAK1) (44) . Of these, TAK1 and PAK1 play a critical role in activating JNK. In the present study, we found that ASK1 is another upstream molecule involved in the activation of JNK by H. pylori.
It has been reported that ASK1 is activated by secreted peptidyl prolyl cis,trans-isomerase of H. pylori and HP0175 through Tolllike receptor-4 (TLR4), resulting in the activation of p38 and after apoptosis (49) . In contrast, other reports rejected the involvement of TLR4 in H. pylori-induced epithelial cell signaling (16, 18, 50) . Our present study revealed that ASK1 activation is clearly dependent on cag PAI and ROS production, which leads to sustained JNK activation but neither p38 nor ERK. Thus, we identified a new mechanism of ASK1 activation, induced by H. pylori.
We showed here that H. pylori-induced JNK activation contains two separate phases, i.e., TAK1 regulates early JNK activation, while ASK1 does sustained JNK activation in late phase. It has been known that the duration of JNK activation in response to TNF-␣, UV-C, anti-Fas, H 2 O 2 , or acetaminophen is important for determining cell fates (5, 12, (51) (52) (53) . Early transient JNK activation is regulated by several upstream molecules, including GSK-3␤ or MEKK1, according to cell type or stimuli (53) (54) (55) and controls cytokine expression, differentiation, and cell proliferation. In contrast, in all reported series, ASK1 is the key regulator of sustained JNK activation, and ASK1-dependent prolonged JNK activation is directly correlated with cell death (3, 5, 12) . We found that sustained JNK activation by cag-positive H. pylori via ASK1 activation also regulates epithelial cell death in a ROS-dependent manner, as well as some sort of cytokine production in a ROSindependent manner. Thus, ASK1 activation may be one of important responses induced by H. pylori during chronic infection.
ROS produced by H. pylori is associated with apoptosis and accumulation of DNA damage, which are considered to lead to atrophy and malignant transformation of the stomach (34, 56) . These reports and our data suggest the possibility that ROS and ASK1 activation might play a role on the development of gastric atrophy, metaplasia, and dysplasia. In mouse gastric carcinogenesis models (57, 58) , apoptosis or cell death causes compensatory proliferation of surrounding cells, which leads to more advanced cancer development, as seen in liver cancer models (39, 59) . Since the role of ASK1 on H. pylori-induced cellular responses is limited to sustained activation of JNK and apoptosis without affecting other MAPK activities or numerous cytokine production, ASK1 inhibition might be a potent targeting therapy for preventing gastric atrophy and following mucosal changes after H. pylori infection, not only for established gastric cancer therapy (11, 13) .
Inhibition of TAK1 induces ROS production through suppression of NF-B or p38 activity and inhibition of antioxidant gene expression for FHC, MnSOD, Hsp25, Nrf2, or Nox1 (38, 39, (60) (61) (62) . Our data suggest that ROS-induced ASK1 activation is critical for sustained JNK activation and apoptosis and that ROS production is enhanced by the inhibition of TAK1 and downstream p38. Moreover, ASK1 conversely inhibits TAK1 and NF-B activation in the setting of H. pylori stimulation. These findings suggest that upstream MAP3Ks, including TAK1 and ASK1, have quite complicated interactions that regulate detailed cellular functions and determine cell fate in response to extracellular stresses or stimuli.
Previous studies have shown that JNK induces BimEL expression during apoptotic responses (63, 64) . In Fig. 5B , BimEL expression was correlated with JNK activation level in both ASK1 siRNA and TAK1 siRNA groups at 24 h after stimulation, suggesting that BimEL expression is JNK dependent in gastric epithelial cells. We also observed that ASK1 knockdown increased antiapoptotic gene expression, which was suppressed by TAK1 knockdown. It is possible that ASK1 regulates H. pylori-induced apop- tosis by two distinct mechanisms, enhancing JNK and BimEL phosphorylation or suppressing antiapoptotic gene expression. We recently reported that ASK1 promotes gastric cancer cell proliferation (11, 65) , showing that ASK1 plays two distinct roles in gastric carcinogenesis as a proliferative or apoptotic signal. Several other genes with such paradoxical functions have been reported. For example, Fas is a prototypical death receptor that regulates tissue homeostasis through the induction of apoptosis but also has a growth-promoting function during tumorigenesis (66) . Thus, apoptosis-promoting molecules such as ASK1 and Fas have different functions and play different roles depending on the extracellular stimuli or the activation status of other MAP3Ks such as TAK1.
In the present study, we focused on the role of ASK1 in epithelial cells because gastric epithelium provides the first line defense against H. pylori. However, in H. pylori-infected gastric mucosa, numerous inflammatory cells migrate into the lamina propria and definitely play crucial roles in inflammation and carcinogenesis (67) (68) (69) (70) (71) . Importantly, ROS and cytokine production from innate immune cells are involved in the pathogenesis of inflammatory diseases (72, 73) , including H. pylori infection (74) (75) (76) (77) (78) . It has been reported that ASK1 controls macrophage cell death and immune responses via ROS (4, 9) , suggesting the importance of this molecule in immune cells. Thus, to clarify the role of ASK1 in vivo and elucidate the relationship between epithelial cell responses and immune cell responses, the mouse Helicobacter infection model will be useful in future studies.
In summary, we report here that (i) H. pylori activates ASK1 in a ROS-dependent manner, (ii) TAK1 and p38 activation by H. pylori affects ROS-ASK1-apoptotic pathways, and (iii) activated ASK1 plays a critical role in H. pylori-induced apoptosis. These results demonstrate that ASK1 is a key molecule in regulation of ROS-related responses in gastric epithelial cells.
